Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Reducing fear responses in phobia patients using brain activity techniques

Official title: Unconscious Reduction of Fear Through Decoded Neuro-Reinforcement

Run by University of California, Los Angeles · NCT06420557 · Data updated 2026-11-12

This study is testing a new way to help people with phobias, like fear of spiders or snakes, by using brain activity techniques to reduce their fear without them having to face their fears directly.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedSeptember 9, 2024
Main results expectedMarch 30, 2027
Study endsMarch 30, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT06420557 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with specific phobias of animals who have normal or corrected vision and hearing.

Probably not a fit

Patients with neurological disorders, severe psychological conditions, or those unable to participate in assessments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This application investigates a novel method of neuro-reinforcement that utilizes decoded fMRI activity to unconsciously reduce fear responses in individuals with specific phobias, such as fear of spiders or snakes. Unlike traditional exposure therapy, which requires conscious confrontation with feared stimuli, this method aims to minimize distress by bypassing conscious awareness. The study employs a double-blind placebo-controlled design to ensure rigorous evaluation of the treatment's efficacy. The primary goals include confirming the method's engagement with the amygdala and assessing its impact on behavioral outcomes related to fear responses.

Why it matters

Potential benefit: If successful, this approach could provide a less distressing and more effective treatment option for individuals suffering from phobias.

How similar studies have gone: While traditional exposure therapies have been widely studied, this specific approach using unconscious neuro-reinforcement is novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individual has normal or corrected to normal vision
2. Individual has normal or corrected to normal hearing
3. Individual is competent to understand informed consent
4. Individual must meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria for specific phobias, animal subtype

Exclusion Criteria:

1. Individual is unable to fill in consent form correctly
2. Individual is unable to respond adequately to screening questions
3. Individual is unable to maintain focus or to sit during assessment
4. Individual has history of: neurological disease or defect (e.g., stroke, traumatic brain injury, schizophrenia or other psychological disorders, or seizures) Individual has vision problems (including cataracts, amblyopia, or glaucoma) Individual presents with: Obsessive Compulsive Disorder, Substance Use Disorder, Bipolar Disorder, Psychosis, neurologic diagnoses or unstable serious medical conditions
5. Participant receives an elevated score on the PHQ-9
6. Individual does not present with more than one object of specific phobia
7. Individual can touch the phobic object category during the pre-treatment Behavioral Approach Test without presenting significant distress
8. Individual is currently prescribed psychotropic medication

Where it's running

  • University of California, Los Angeles
    Los Angeles, California, United States
    Recruiting

Study contacts

  • Principal investigator: Michelle G Craske, PhD — University of California, Los Angeles
  • Study coordinator: Gabriel J Fiol, B.A.
  • Email: gfiol@psych.ucla.edu
  • Phone: 7252228834

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.